Out of 64 companies listed in 2021, 34 are trading above their respective issue prices, with at least six of them still trading more than 1...

Grover also recently wrote to the board on the issue of Koladiya’s alleged stake in the firm, asking it to remove him from the company at o...

Paytm’s parent firm One97 Communications is looking to break even on earnings before interest, taxes, depreciation, and amortisation (Ebdit...

The Rs 100 crore IPO by Nureca rewarded investors the most, with a return of up to 323 per cent over the issue price of Rs 400. The company...

One of the least surprising beneficiaries of the pandemic has been India's healthtech sector, which has seen a wave of consolidation.

Today we bring you the last in the series of interviews we've been publishing over the past month with all the winners of The Economic Time...

PharmEasy founders — Siddharth Shah, Dhaval Shah, Dhramil Sheth, Harsh Parekh and Hardik Dedhia — have received new stock options ahead of ...

“We like the diagnostic business, we like Vijay Diagnostics and we also like their valuation. I think a big thumps up has been received in ...

Marketmen tracking grey market moves said activity may pick up pace early next week. The Rs 1,894 crore Vijaya Diagnostic Centre IPO would ...

Here are key things you should know about the Rs 1,894-crore IPO of Vijaya Diagnostic Centre.

We take a closer look at four of the weirdest cryptocurrencies of all time

The committee of independent directors of Mindtree has appointed Khaitan and Co as legal counsel.

Philips’ transformation from being a trusted electronics brand into a healthcare services company is not an aberration, reckon branding exp...

His current investing approach, ‘Peaceful Investing,’ was developed from a lot of lessons.

Fortis announcement to acquire Fortis Int. has come as a surprise and puzzled shareholders by the apparent change in the strategy